SARS-CoV-2 Services

To aid with the ongoing, emerging SARS-CoV-2 or novel coronavirus outbreak, Structure Based Design is offering recombinant SARS-CoV-2 main protease (Mpro or 3CLpro) and recombinant SARS-CoV-2 RNA Polymerase (nsp12-nsp8-nsp7), the two most notable SARS-CoV-2 drug targets, for your drug development needs. Other proteins from the SARS-CoV-2 virus or related COVID-19 research may expressed and purified upon request.

In addition to our protein production services, Structure Based Design has set up a pipeline to co-crystalize SARS-CoV-2 Mpro in complex with candidate Mpro inhibitors.

Please contact us at to inquire about our COVID-19 related services or if we can assist you with your coronavirus research in any way.